{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T21:25:08Z","timestamp":1777929908601,"version":"3.51.4"},"reference-count":15,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Palliative Medicine Reports"],"published-print":{"date-parts":[[2023,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>When methadone is used to treat cancer pain, the Japanese health insurance system recommends to determine the starting dose according to the equivalency conversion table based on the morphine-equivalent daily dose (MEDD) of prior opioids proposed by the National Comprehensive Cancer Network. Owing to the wide range in variability of the conversion table, methadone increases the incidence of daytime sleepiness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>To identify the factors associated with daytime sleepiness and propose a conversion ratio from pretreatment MEDD to oral methadone that decreases the risk of daytime sleepiness.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Retrospective cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting\/Subjects:<\/jats:title>\n                    <jats:p>One hundred patients who started oral methadone to relieve cancer pain at Ashiya Municipal Hospital (Hyogo, Japan) from January 1, 2013, to August 31, 2022, were enrolled.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Measurements:<\/jats:title>\n                    <jats:p>The primary endpoint, the conversion ratio from pretreatment MEDD to oral methadone without daytime sleepiness, was determined using receiver operator characteristic (ROC) curve analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The incidence of daytime sleepiness within seven days of methadone initiation was 40.0%. The factors identified as contributing to daytime sleepiness were pretreatment MEDD (odds ratio [OR]: 0.941, 95% confidence interval [CI]: 0.916\u20130.966,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;0.001) and methadone dose (OR: 1.395, 95% CI: 1.178\u20131.652,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;0.001). The conversion ratio from pretreatment MEDD to oral methadone was 0.24, with an area under the ROC curve of 0.909 (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Daytime sleepiness developed when methadone dose is high relative to pretreatment MEDD. To the best of our knowledge, this is the first study to suggest the conversion ratio from pretreatment MEDD to oral methadone without causing daytime sleepiness.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/pmr.2023.0007","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T09:44:42Z","timestamp":1690537482000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Identification of Factors Contributing to Methadone-Induced Daytime Sleepiness in Cancer Patients and Proposal of the Conversion Ratio from Other Opioids to Oral Methadone: A Retrospective Cohort Study"],"prefix":"10.1177","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7170-6938","authenticated-orcid":false,"given":"Miho","family":"Takemura","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy Research and Education, Osaka University Graduate School of Pharmaceutical Sciences, Suita, Japan."},{"name":"Department of Pharmacy, Ashiya Municipal Hospital, Ashiya, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9089-9387","authenticated-orcid":false,"given":"Kazuyuki","family":"Niki","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Research and Education, Osaka University Graduate School of Pharmaceutical Sciences, Suita, Japan."},{"name":"Department of Pharmacy, Ashiya Municipal Hospital, Ashiya, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Ashiya Municipal Hospital, Ashiya, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Matsuda","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Ashiya Municipal Hospital, Ashiya, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makie","family":"Kohno","sequence":"additional","affiliation":[{"name":"Department of Palliative Care, Ashiya Municipal Hospital, Ashiya, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikiko","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Research and Education, Osaka University Graduate School of Pharmaceutical Sciences, Suita, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/383819a0"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/74.2.188"},{"issue":"3","key":"e_1_3_4_4_2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3892\/etm.2021.10437","article-title":"Molecular mechanisms of opioid tolerance: From opioid receptors to inflammatory mediators (Review)","volume":"22","author":"Zhou J","year":"2021","unstructured":"Zhou J, , Ma R, , Jin Y, et al. Molecular mechanisms of opioid tolerance: From opioid receptors to inflammatory mediators (Review). Exp Ther Med, 2021; 22(3):1004; doi: 10.3892\/etm.2021.10437","journal-title":"Exp Ther Med"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.06.025"},{"issue":"2","key":"e_1_3_4_6_2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0022-3565(24)38234-5","article-title":"d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia","volume":"289","author":"Davis AM","year":"1999","unstructured":"Davis AM, , Inturrisi CE. d-Methadone blocks morphine tolerance and N-methyl-D-aspartate-induced hyperalgesia. J Pharmacol Exp Ther, 1999; 289(2):1048\u20131053.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"e_1_3_4_7_2","first-page":"CD003971","article-title":"Methadone for cancer pain","volume":"2","author":"Nicholson AB","year":"2017","unstructured":"Nicholson AB, , Watson GR, , Derry S, et al. Methadone for cancer pain. Cochrane Database Syst Rev, 2017; 2(2):CD003971; doi: 10.1002\/14651858.CD003971.pub4","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"e_1_3_4_8_2","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s11325-020-02123-z","article-title":"Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment","volume":"24","author":"Baldassarri SR","year":"2020","unstructured":"Baldassarri SR, , Beitel M, , Zinchuk A, et al. Correlates of sleep quality and excessive daytime sleepiness in people with opioid use disorder receiving methadone treatment. Sleep Breath, 2020; 24(4):1729\u20131737; doi: 10.1007\/s11325-020-02123-z","journal-title":"Sleep Breath"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2010.08.007"},{"issue":"6","key":"e_1_3_4_10_2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.5664\/jcsm.27350","article-title":"Subjective daytime sleepiness and daytime function in patients on stable methadone maintenance treatment: Possible mechanisms","volume":"4","author":"Wang D","year":"2008","unstructured":"Wang D, , Teichtahl H, , Goodman C, et al. Subjective daytime sleepiness and daytime function in patients on stable methadone maintenance treatment: Possible mechanisms. J Clin Sleep Med, 2008; 4(6):557\u2013562.","journal-title":"J Clin Sleep Med"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.5664\/jcsm.26908"},{"issue":"1","key":"e_1_3_4_12_2","first-page":"81","article-title":"Central apnea during stage 3,4 sleep","volume":"3","author":"Berry RB","year":"2007","unstructured":"Berry RB. Central apnea during stage 3,4 sleep. J Clin Sleep Med, 2007; 3(1):81\u201382.","journal-title":"J Clin Sleep Med"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06.2287"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.03.172"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.09.014"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2017.07.001"}],"container-title":["Palliative Medicine Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/pmr.2023.0007","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/pmr.2023.0007","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/pmr.2023.0007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T23:57:16Z","timestamp":1777679836000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/pmr.2023.0007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["10.1089\/pmr.2023.0007"],"URL":"https:\/\/doi.org\/10.1089\/pmr.2023.0007","relation":{},"ISSN":["2689-2820","2689-2820"],"issn-type":[{"value":"2689-2820","type":"print"},{"value":"2689-2820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"article-number":"pmr.2023.0007"}}